Editorial: Pharmacogenomics of Adverse Drug Reactions

被引：1
|
作者：
Siddiqui, Moneeza K. [1 ]
Luzum, Jasmine [2 ]
Coenen, Marieke [3 ]
Mahmoudpour, Seyed Hamidreza [4 ]
机构：
[1] Univ Dundee, Ninewells Hosp & Sch Med, Pat McPherson Ctr Pharmacogenet & Pharmacogen, Div Populate Hlth & Genom, Dundee, Angus, Scotland
[2] Univ Michigan, Dept Clini Pharm, Coll Pharm, Ann Arbor, MI USA
[3] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Radboud Inst Hlth Sci, Nijmegen, Netherlands
[4] Univ Med Ctr Mainz, Inst Med Biostat Epidemiol Informat IMBEI, Dept Biometry & Bioinformat, Mainz, Germany
来源：
FRONTIERS IN GENETICS | 2022年 / 13卷
关键词：
pharmacogenomics; adverse drug reactions (ADRs); pharmacogenetics; personalized medicine; adverse (side) effects;
D O I：
10.3389/fgene.2022.859909
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database
    Tanoshima, Reo
    Khan, Amna
    Biala, Agnieszka K.
    Trueman, Jessica N.
    Drogemoller, Britt I.
    Wright, Galen E. B.
    Hasbullah, Jafar S.
    Groeneweg, Gabriella S. S.
    Ross, Colin J. D.
    Carleton, Bruce C.
    Rassekh, Shahrad R.
    Amstutz, Ursula
    Loucks, Catrina
    Higginson, Michelle
    Miao, Fudan
    Bendyshe-Walton, Tessa
    Trueman, Jessica N.
    McGoldrick, Nicole
    Biala, Agnieszka K.
    Khan, Amna
    Tanoshima, Miki
    Bhavsar, Amit P.
    Guilcher, Gregory
    Honcharik, Nick
    't Jong, Geert
    Israels, Sara
    Cuvelier, Geoff
    Staub, Michelle
    Rieder, Michael
    Faught, Lauren
    Ito, Shinya
    Nathan, Paul
    Karande, Smita
    Shear, Neil H.
    Vaillancourt, Regis
    Johnston, Donna
    Nguyen, Kimmy
    Bussieres, Jean-Francois
    Lebel, Denis
    Jean-Louis, Jennifer
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (03) : 356 - 363
  • [22] Pharmacogenomics: the genomics of drug response
    March, R
    YEAST, 2000, 17 (01) : 16 - 21
  • [23] Adverse Drug Reactions to Anti-TB Drugs: Pharmacogenomics Perspective for Identification of Host Genetic Markers
    Sahu, Roshan Kumar
    Singh, Kan
    Subodh, Swati
    CURRENT DRUG METABOLISM, 2015, 16 (07) : 538 - 552
  • [24] A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
    Kloypan, Chiraphat
    Koomdee, Napatrupron
    Satapornpong, Patompong
    Tempark, Therdpong
    Biswas, Mohitosh
    Sukasem, Chonlaphat
    PHARMACEUTICALS, 2021, 14 (11)
  • [25] Adverse drug reactions
    Cho, Min-Kyung
    Kang, Dong Yoon
    Kang, Hye-Ryun
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2019, 62 (09): : 472 - 479
  • [26] Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping review
    Yow, Hui-Yin
    Hamzah, Sharina
    Suppiah, Vijayaprakash
    Abdul Rahim, Nusaibah
    ASIAN BIOMEDICINE, 2023, 17 (03) : 95 - 114
  • [27] Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade
    Alessandrini, Marco
    Chaudhry, Mamoonah
    Dodgen, Tyren M.
    Pepper, Michael S.
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2016, 20 (10) : 593 - 603
  • [28] Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital
    La Russa, Raffaele
    Fineschi, Vittorio
    Di Sanzo, Mariantonia
    Gatto, Vittorio
    Santurro, Alessandro
    Martini, Gabriella
    Scopetti, Matteo
    Frati, Paola
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (03) : 274 - 281
  • [29] Biomarkers of adverse drug reactions
    Carr, Daniel F.
    Pirmohamed, Munir
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 243 (03) : 291 - 299
  • [30] Translating pharmacogenomics into personalized medicine and drug development
    Zhang, Wei
    Chan, Thomas Y. K.
    Fan, Lan
    Guo, Ying
    Zhou, Hong-Hao
    PERSONALIZED MEDICINE, 2012, 9 (01) : 93 - 97
12345